Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Esports Entertainment Group to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted By M-Vest on March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT
-
Entravision Announces Participation in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest
-
Esports Technologies to Participate in the 2022 Virtual Growth Conference
-
American Software to Participate in the 2022 Virtual Growth Conference
-
Interlink Electronics, Inc. (NASDAQ: LINK) to Participate in the 2022 Virtual Growth Conference
-
Creative Realities, Inc. to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT
-
Cosmos Holdings to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest
-
Palisade Bio (Nasdaq: PALI) to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group and Hosted by M-Vest
-
Dermata Therapeutics to Participate in the 2022 Maxim Group Virtual Growth Conference
-
HCW Biologics to Present at 2022 Virtual Growth Conference Sponsored by the Maxim Group and M-Vest
-
Lineage to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC on March 28, 2022
-
NEXGEL to Present at Maxim Group's 2022 Virtual Growth Conference
-
VistaGen to Participate in Fireside Chat at Maxim Group 2022 Virtual Growth Conference
-
HCW Biologics to Present at 2022 Virtual Growth Conference Sponsored by the Maxim Group and M-Vest
-
VistaGen to Participate in Fireside Chat at Maxim Group 2022 Virtual Growth Conference
-
ORTHO REGENERATIVE TECHNOLOGIES TO PARTICIPATE IN THE 2022 VIRTUAL GROWTH CONFERENCE PRESENTED BY MAXIM GROUP LLC AND HOSTED BY M-VEST
-
Pixium Vision to participate in the 2022 Virtual Growth Conference presented by Maxim Group LLC and hosted by M-Vest on March 28 - 30
-
Addex to Present at the Bio-Europe Spring 2022 and Maxim Group – 2022 Virtual Growth Conferences
-
Pixium Vision to participate in the 2022 Virtual Growth Conference presented by Maxim Group LLC and hosted by M-Vest on March 28 - 30
-
Addex to Present at the Bio-Europe Spring 2022 and Maxim Group – 2022 Virtual Growth Conferences
-
Elys Game Technology to Participate in 2022 Virtual Growth Conference Presented by Maxim Group
-
Horizon Technology Finance to Participate in Maxim Group/M-Vest Virtual Growth Conference
-
Identity & Access Management (IAM) Solutions Provider BIO-key to Participate in Maxim Group Emerging Growth Conference, March 28-30th
-
Beroni Group to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th – 30th from 9:00 a.m. - 5:00 p.m. EDT
-
Beroni Group to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th – 30th from 9:00 a.m. - 5:00 p.m. EDT
-
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Participate at the 2022 Virtual Growth Conference
-
Wrap Technologies to Participate in the 2022 Virtual Growth Conference by Maxim Group LLC on March 28-30, 2022
-
Imperial Petroleum Inc. (IMPP) Closes $60M Equity Offering
-
Imperial Petroleum Announces Closing of Upsized $60 Million Underwritten Public Offering
-
Bion to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC
-
Applied DNA to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest on March 28th – 30th from 9:00 a.m. - 5:00 p.m. EDT
-
Society Pass Incorporated (SoPa) (Nasdaq: SOPA) to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC
-
Society Pass Incorporated (SoPa) (Nasdaq: SOPA) to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC
-
Society Pass Incorporated (SoPa) (Nasdaq: “SOPA”) to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC
-
Society Pass Incorporated (SoPa) (Nasdaq: “SOPA”) to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC
-
Lobe Sciences Ltd. to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest on March 28th - 30th from 9:00 A.M. - 5:00 P.M. EDT
-
Atossa Therapeutics to Present at the Maxim Group 2022 Virtual Growth Conference
-
ABVC BioPharma to Present at the Maxim Group 2022 Virtual Growth Conference
-
ABVC BioPharma to Present at the Maxim Group 2022 Virtual Growth Conference
-
ABVC BioPharma to Present at the Maxim Group 2022 Virtual Growth Conference
-
ABVC BioPharma to Present at the Maxim Group 2022 Virtual Growth Conference
-
CareCloud to Participate in the 2022 Virtual Growth Conference
-
EzFill to Participate in Maxim Group Virtual Growth Conference
-
CareCloud to Participate in the 2022 Virtual Growth Conference
-
EzFill to Participate in Maxim Group Virtual Growth Conference
-
Dolphin Entertainment to Participate in the Maxim Group 2022 Virtual Growth Conference on Tuesday, March 29 at 2:00 pm ET
-
Usio to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest - March 28th – 30th from 9:00 a.m. - 5:00 p.m. EDT
-
CNS Pharmaceuticals to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest
-
Panbela to Participate in a Panel Discussion: “Pancreatic Cancer- Turning the Tide for One of the Most Challenging Indications in Oncology,” at the Maxim Virtual Growth Conference on March 28, 202
-
Panbela to Participate in a Panel Discussion: “Pancreatic Cancer- Turning the Tide for One of the Most Challenging Indications in Oncology,” at the Maxim Virtual Growth Conference on March 28, 202
